Methylmalonic Acidemia (MMA) Global Market Report 2025

Global Methylmalonic Acidemia (MMA) Market Report 2025

Methylmalonic Acidemia (MMA) Global Market Report 2025 - By Indication (Acidosis, Ketosis, Hyperammonemia, Hypoglycaemia, Hyperglycaemia, Neutropenia, Other Indications), By Disorder Type (Homocystinuria, Isolated Methylmalonic Acidurias, Combined methylmalonic Aciduria), By Distribution Channel (Hospitals, Pharmacies, Clinics, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Name: Methylmalonic Acidemia (MMA) Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Methylmalonic Acidemia (MMA) Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : April 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Methylmalonic Acidemia (MMA) Global Market Report 2025

Proud Members Of

What Is Covered Under Methylmalonic Acidemia (MMA) Market?

Methylmalonic acidemia (MMA) is a rare, inherited metabolic disorder in which the body is unable to properly break down specific proteins and fats due to a deficiency in the enzyme methylmalonyl-CoA mutase or a related coenzyme, vitamin B12. The symptoms of MMA can vary in severity but often include vomiting, lethargy, poor feeding, developmental delay, seizures, and failure to thrive.

The main indication types of methylmalonic acidemia (MMA) are acidosis, ketosis, hyperammonemia, hypoglycemia, hyperglycemia, Neutropenia, and other indications. Acidosis is a condition in which there is an excess of acid in the blood, leading to a lower-than-normal pH level. There are different disorder types, like homocystinuria, isolated methylmalonic acidurias, and combined methylmalonic aciduria. It is through various distribution channels, such as hospitals, Pharmacies, clinics, and other distribution channels.

Methylmalonic Acidemia (MMA) Market Size and growth rate 2025 to 2029: Graph

What Is The Methylmalonic Acidemia (MMA) Market Size 2025 And Growth Rate?

The methylmalonic acidemia (MMA) market size has grown strongly in recent years. It will grow from $9.39 billion in 2024 to $9.97 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to the increasing incidence of metabolic disorders and vitamin deficiencies, increased healthcare expenditure, rise in health consciousness, increasing prevalence of genetic disorders, and growing demand from various end-user industries.

What Is The Methylmalonic Acidemia (MMA) Market Growth Forecast?

The methylmalonic acidemia (MMA) market size is expected to see strong growth in the next few years. It will grow to $12.50 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing newborn screening programs, increased awareness among healthcare professionals, a rise in gene therapy advancements, rising investments in rare disease research, and increasing availability of specialized treatments. Major trends in the forecast period include advancements in gene editing technologies, advanced diagnostic techniques for early detection, advancements in enzyme replacement therapies, adoption of precision medicine approaches, and adoption of newborn genetic screening programs.

Book your 30 minutes free consultation with our research experts

How Is The Methylmalonic Acidemia (MMA) Market Segmented?

The methylmalonic acidemia (MMA) market covered in this report is segmented –

1) By Indication: Acidosis, Ketosis, Hyperammonemia, Hypoglycaemia, Hyperglycaemia, Neutropenia, Other Indications

2) By Disorder Type: Homocystinuria, Isolated Methylmalonic Acidurias, Combined methylmalonic Aciduria

3) By Distribution Channel: Hospitals, Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Acidosis: Metabolic Acidosis, Lactic Acidosis

2) By Ketosis: Starvation-Induced Ketosis, Diabetic Ketoacidosis

3) By Hyperammonemia: Acute Hyperammonemia, Chronic Hyperammonemia

4) By Hypoglycemia: Fasting Hypoglycemia, Reactive Hypoglycemi

5) By Hyperglycemia: Transient Hyperglycemia, Persistent Hyperglycemia

6) By Neutropenia: Severe Neutropenia, Cyclic Neutropenia

7) By Other Indications: Failure to Thrive, Developmental Delays, Neurological Symptoms, Renal Dysfunction

What Is Driving The Methylmalonic Acidemia (MMA) Market? Rising Incidence Of Metabolic Disorders And Vitamin Deficiencies Driving The Growth Of The Market Due To Impaired Vitamin B12 Metabolism

The increasing incidence of metabolic disorders and vitamin deficiencies is expected to propel the growth of the methylmalonic acidemia (MMA) market going forward. Metabolic disorders are a group of conditions in which the body has trouble processing certain nutrients, producing energy, or regulating chemical reactions within cells. Vitamin deficiencies occur when the body lacks enough specific vitamins to perform normal functions. The rise in metabolic disorders and vitamin deficiencies is due to unhealthy diets, sedentary lifestyles, and increased stress levels. Modern diets are often high in processed foods, sugars, and unhealthy fats while low in essential nutrients, leading to deficiencies in vitamins and minerals. Metabolic disorders and vitamin deficiencies, particularly vitamin B12 deficiency, impair methylmalonyl-CoA metabolism, accumulating methylmalonic acid and exacerbating methylmalonic acidemia (MMA). For instance, in November 2024, according to the National Institutes of Health, a US-based government agency, the prevalence of vitamin B12 deficiency increased from 4.6% to 5.2%, representing an additional 507 cases between the third and fourth quarters of 2023. Therefore, the increasing incidence of metabolic disorders and vitamin deficiencies drives the growth of the methylmalonic acidemia (MMA) market.

Who Are The Major Players In The Global Methylmalonic Acidemia (MMA) Market?

Major companies operating in the methylmalonic acidemia (MMA) market are Moderna Inc., Lonza Group Ltd., Alexion Pharmaceuticals Inc., PTC Therapeutics Inc., Ironwood Pharmaceuticals Inc., Wockhardt Limited, Spectrum Chemical Manufacturing Corp., Asklepios BioPharmaceutical Inc. (AskBio), Selecta Biosciences Inc., BTG International Inc., BridgeBio Pharma Inc., VectivBio Holding AG, Supriya Lifescience Ltd., Recordati Rare Diseases Inc., Agios Pharmaceuticals Inc., AdvaCare Pharma USA LLC, LogicBio Therapeutics Inc., HemoShear Therapeutics LLC, Manus Aktteva Biopharma LLP, Deccan Nutraceuticals Pvt. Ltd.

What Are The Key Trends Of The Global Methylmalonic Acidemia (MMA) Market? Innovative mRNA-Based Therapies Pave The Way For Advanced Treatments

Major companies operating in the methylmalonic acidemia (MMA) market are focusing on developing innovative solutions, such as mRNA-based therapies, to improve treatment outcomes by targeting the underlying genetic causes of MMA and enhancing enzyme function to reduce the accumulation of toxic metabolites in affected individuals. mRNA-based therapies are a type of treatment that uses messenger RNA to instruct cells to produce specific proteins that can help prevent or treat diseases, such as genetic disorders or infections. For instance, In June 2024, Moderna, Inc., a US-based pharmaceutical and biotechnology company, received U.S. Food and Drug Administration (FDA) approval for including mRNA-3705 in the START pilot program, marking a significant step in advancing treatments for rare diseases. mRNA-3705 is an investigational therapy for methylmalonic acidemia (MMA) caused by MUT deficiency, designed to restore the missing enzyme using mRNA technology. The therapy leverages Moderna's proprietary lipid nanoparticle (LNP) system, also utilized in the mRNA-3927 program for propionic acidemia. The FDA has granted mRNA-3705 orphan drugs, fast track, and rare pediatric disease designations, facilitating its accelerated development and clinical progress.

What Are Latest Mergers And Acquisitions In The Methylmalonic Acidemia (MMA) Market? Alexion Expands Genomic Medicine Portfolio With Logic bio Acquisition

In October 2022, Alexion Pharmaceuticals, a US-based biopharmaceutical company, acquired LogicBio Therapeutics for approximately $68.2 million. With this acquisition, Alexion will accelerate its growth in genomic medicines by leveraging unique technology, a skilled rare disease research and development team, and expertise in preclinical development. LogicBio Therapeutics, Inc. is a US-based biotechnology company focused on developing gene-editing and gene therapy solutions for rare genetic diseases, including methylmalonic acidemia (MMA).

What Is The Regional Outlook For The Global Methylmalonic Acidemia (MMA) Market?

North America was the largest region in the methylmalonic acidemia (MMA) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the methylmalonic acidemia (MMA) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the methylmalonic acidemia (MMA) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Methylmalonic Acidemia (MMA) Market?

The methylmalonic acidemia (MMA) market consists of revenues earned by entities by providing services such as medical management, dietary support, and vitamin and medication therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The methylmalonic acidemia market includes sales of hydroxocobalamin, vitamin B12 tablets, other pharmaceutical and therapeutic products, dietary products, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Methylmalonic Acidemia (MMA) Industry?

The methylmalonic acidemia (MMA) market research report is one of a series of new reports from The Business Research Company that provides methylmalonic acidemia (MMA) market statistics, including the methylmalonic acidemia (MMA) industry global market size, regional shares, competitors with the methylmalonic acidemia (MMA) market share, detailed methylmalonic acidemia (MMA) market segments, market trends, and opportunities, and any further data you may need to thrive in the methylmalonic acidemia (MMA) industry. This methylmalonic acidemia (MMA) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Methylmalonic Acidemia MMA Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$9.97 billion
Revenue Forecast In 2034	$12.50 billion
Growth Rate	CAGR of 5.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The methylmalonic acidemia (MMA) market covered in this report is segmented – 1) By Indication: Acidosis, Ketosis, Hyperammonemia, Hypoglycaemia, Hyperglycaemia, Neutropenia, Other Indications 2) By Disorder Type: Homocystinuria, Isolated Methylmalonic Acidurias, Combined methylmalonic Aciduria 3) By Distribution Channel: Hospitals, Pharmacies, Clinics, Other Distribution Channels Subsegments: 1) By Acidosis: Metabolic Acidosis, Lactic Acidosis 2) By Ketosis: Starvation-Induced Ketosis, Diabetic Ketoacidosis 3) By Hyperammonemia: Acute Hyperammonemia, Chronic Hyperammonemia 4) By Hypoglycemia: Fasting Hypoglycemia, Reactive Hypoglycemi 5) By Hyperglycemia: Transient Hyperglycemia, Persistent Hyperglycemia 6) By Neutropenia: Severe Neutropenia, Cyclic Neutropenia 7) By Other Indications: Failure to Thrive, Developmental Delays, Neurological Symptoms, Renal Dysfunction
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Moderna Inc., Lonza Group Ltd., Alexion Pharmaceuticals Inc., PTC Therapeutics Inc., Ironwood Pharmaceuticals Inc., Wockhardt Limited, Spectrum Chemical Manufacturing Corp., Asklepios BioPharmaceutical Inc. (AskBio), Selecta Biosciences Inc., BTG International Inc., BridgeBio Pharma Inc., VectivBio Holding AG, Supriya Lifescience Ltd., Recordati Rare Diseases Inc., Agios Pharmaceuticals Inc., AdvaCare Pharma USA LLC, LogicBio Therapeutics Inc., HemoShear Therapeutics LLC, Manus Aktteva Biopharma LLP, Deccan Nutraceuticals Pvt. Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options
Market Size Value In 2025	$9.97 billion
Revenue Forecast In 2034	$12.50 billion
Growth Rate	CAGR of 5.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The methylmalonic acidemia (MMA) market covered in this report is segmented – 1) By Indication: Acidosis, Ketosis, Hyperammonemia, Hypoglycaemia, Hyperglycaemia, Neutropenia, Other Indications 2) By Disorder Type: Homocystinuria, Isolated Methylmalonic Acidurias, Combined methylmalonic Aciduria 3) By Distribution Channel: Hospitals, Pharmacies, Clinics, Other Distribution Channels Subsegments: 1) By Acidosis: Metabolic Acidosis, Lactic Acidosis 2) By Ketosis: Starvation-Induced Ketosis, Diabetic Ketoacidosis 3) By Hyperammonemia: Acute Hyperammonemia, Chronic Hyperammonemia 4) By Hypoglycemia: Fasting Hypoglycemia, Reactive Hypoglycemi 5) By Hyperglycemia: Transient Hyperglycemia, Persistent Hyperglycemia 6) By Neutropenia: Severe Neutropenia, Cyclic Neutropenia 7) By Other Indications: Failure to Thrive, Developmental Delays, Neurological Symptoms, Renal Dysfunction
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Moderna Inc., Lonza Group Ltd., Alexion Pharmaceuticals Inc., PTC Therapeutics Inc., Ironwood Pharmaceuticals Inc., Wockhardt Limited, Spectrum Chemical Manufacturing Corp., Asklepios BioPharmaceutical Inc. (AskBio), Selecta Biosciences Inc., BTG International Inc., BridgeBio Pharma Inc., VectivBio Holding AG, Supriya Lifescience Ltd., Recordati Rare Diseases Inc., Agios Pharmaceuticals Inc., AdvaCare Pharma USA LLC, LogicBio Therapeutics Inc., HemoShear Therapeutics LLC, Manus Aktteva Biopharma LLP, Deccan Nutraceuticals Pvt. Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Methylmalonic Acidemia (MMA) Market Characteristics

3. Methylmalonic Acidemia (MMA) Market Trends And Strategies

4. Methylmalonic Acidemia (MMA) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Methylmalonic Acidemia (MMA) Growth Analysis And Strategic Analysis Framework

5.1. Global Methylmalonic Acidemia (MMA) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Methylmalonic Acidemia (MMA) Market Growth Rate Analysis

5.4. Global Methylmalonic Acidemia (MMA) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Methylmalonic Acidemia (MMA) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Methylmalonic Acidemia (MMA) Total Addressable Market (TAM)

6. Methylmalonic Acidemia (MMA) Market Segmentation

6.1. Global Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acidosis

Ketosis

Hyperammonemia

Hypoglycaemia

Hyperglycaemia

Neutropenia

Other Indications

6.2. Global Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Homocystinuria

Isolated Methylmalonic Acidurias

Combined methylmalonic Aciduria

6.3. Global Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Pharmacies

Clinics

Other Distribution Channels

6.4. Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Acidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Metabolic Acidosis

Lactic Acidosis

6.5. Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Ketosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Starvation-Induced Ketosis

Diabetic Ketoacidosis

6.6. Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Hyperammonemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Hyperammonemia

Chronic Hyperammonemia

6.7. Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Hypoglycemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fasting Hypoglycemia

Reactive Hypoglycemi

6.8. Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Neutropenia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Severe Neutropenia

Cyclic Neutropenia

6.9. Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Failure to Thrive

Developmental Delays

Neurological Symptoms

Renal Dysfunction

7. Methylmalonic Acidemia (MMA) Market Regional And Country Analysis

7.1. Global Methylmalonic Acidemia (MMA) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Methylmalonic Acidemia (MMA) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Methylmalonic Acidemia (MMA) Market

8.1. Asia-Pacific Methylmalonic Acidemia (MMA) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Methylmalonic Acidemia (MMA) Market

9.1. China Methylmalonic Acidemia (MMA) Market Overview

9.2. China Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Methylmalonic Acidemia (MMA) Market

10.1. India Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Methylmalonic Acidemia (MMA) Market

11.1. Japan Methylmalonic Acidemia (MMA) Market Overview

11.2. Japan Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Methylmalonic Acidemia (MMA) Market

12.1. Australia Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Methylmalonic Acidemia (MMA) Market

13.1. Indonesia Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Methylmalonic Acidemia (MMA) Market

14.1. South Korea Methylmalonic Acidemia (MMA) Market Overview

14.2. South Korea Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Methylmalonic Acidemia (MMA) Market

15.1. Western Europe Methylmalonic Acidemia (MMA) Market Overview

15.2. Western Europe Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Methylmalonic Acidemia (MMA) Market

16.1. UK Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Methylmalonic Acidemia (MMA) Market

17.1. Germany Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Methylmalonic Acidemia (MMA) Market

18.1. France Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Methylmalonic Acidemia (MMA) Market

19.1. Italy Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Methylmalonic Acidemia (MMA) Market

20.1. Spain Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Methylmalonic Acidemia (MMA) Market

21.1. Eastern Europe Methylmalonic Acidemia (MMA) Market Overview

21.2. Eastern Europe Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Methylmalonic Acidemia (MMA) Market

22.1. Russia Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Methylmalonic Acidemia (MMA) Market

23.1. North America Methylmalonic Acidemia (MMA) Market Overview

23.2. North America Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Methylmalonic Acidemia (MMA) Market

24.1. USA Methylmalonic Acidemia (MMA) Market Overview

24.2. USA Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Methylmalonic Acidemia (MMA) Market

25.1. Canada Methylmalonic Acidemia (MMA) Market Overview

25.2. Canada Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Methylmalonic Acidemia (MMA) Market

26.1. South America Methylmalonic Acidemia (MMA) Market Overview

26.2. South America Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Methylmalonic Acidemia (MMA) Market

27.1. Brazil Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Methylmalonic Acidemia (MMA) Market

28.1. Middle East Methylmalonic Acidemia (MMA) Market Overview

28.2. Middle East Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Methylmalonic Acidemia (MMA) Market

29.1. Africa Methylmalonic Acidemia (MMA) Market Overview

29.2. Africa Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Methylmalonic Acidemia (MMA) Market Competitive Landscape And Company Profiles

30.1. Methylmalonic Acidemia (MMA) Market Competitive Landscape

30.2. Methylmalonic Acidemia (MMA) Market Company Profiles

30.2.1. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Alexion Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. PTC Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Ironwood Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Methylmalonic Acidemia (MMA) Market Other Major And Innovative Companies

31.1. Wockhardt Limited

31.2. Spectrum Chemical Manufacturing Corp.

31.3. Asklepios BioPharmaceutical Inc. (AskBio)

31.4. Selecta Biosciences Inc.

31.5. BTG International Inc.

31.6. BridgeBio Pharma Inc.

31.7. VectivBio Holding AG

31.8. Supriya Lifescience Ltd.

31.9. Recordati Rare Diseases Inc.

31.10. Agios Pharmaceuticals Inc.

31.11. AdvaCare Pharma USA LLC

31.12. LogicBio Therapeutics Inc.

31.13. HemoShear Therapeutics LLC

31.14. Manus Aktteva Biopharma LLP

31.15. Deccan Nutraceuticals Pvt. Ltd.

32. Global Methylmalonic Acidemia (MMA) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Methylmalonic Acidemia (MMA) Market

34. Recent Developments In The Methylmalonic Acidemia (MMA) Market

35. Methylmalonic Acidemia (MMA) Market High Potential Countries, Segments and Strategies

35.1 Methylmalonic Acidemia (MMA) Market In 2029 - Countries Offering Most New Opportunities

35.2 Methylmalonic Acidemia (MMA) Market In 2029 - Segments Offering Most New Opportunities

35.3 Methylmalonic Acidemia (MMA) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Acidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Ketosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Hyperammonemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Hypoglycemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Neutropenia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Methylmalonic Acidemia (MMA) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Methylmalonic Acidemia (MMA) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Moderna Inc. Financial Performance

Table 81: Lonza Group Ltd. Financial Performance

Table 82: Alexion Pharmaceuticals Inc. Financial Performance

Table 83: PTC Therapeutics Inc. Financial Performance

Table 84: Ironwood Pharmaceuticals Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Acidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Ketosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Hyperammonemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Hypoglycemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Neutropenia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Methylmalonic Acidemia (MMA) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Methylmalonic Acidemia (MMA) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Moderna Inc. Financial Performance

Figure 81: Lonza Group Ltd. Financial Performance

Figure 82: Alexion Pharmaceuticals Inc. Financial Performance

Figure 83: PTC Therapeutics Inc. Financial Performance

Figure 84: Ironwood Pharmaceuticals Inc. Financial Performance

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Global Mycoplasma Testing Market 2022 – Market Opportunities And Strategies

Latest Hospice Care Market Growth Study 2022-2026 By The Business Research Company

The Healthcare Education Market Share, Market Size, And Growth Rate 2022

Global Healthcare Distribution Market 2022 – Market Opportunities And Strategies

Sinus Dilation Devices Global Market Report 2025 – By Product (Balloon Sinus Dilation Devices, Endoscopes, Functional Endoscopic Sinus Surgery (FESS) Instruments Set, Sinus Stents or Implants, Other Products), By Procedure (Standalone, Hybrid), By Application (Adult, Pediatric), By End User (Hospitals, ENT Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence (AI) Engineering Global Market Report 2025 – By Solution (Hardware, Software, Services), By Technology (Deep Learning, Machine Learning, Natural Language Processing, Computer Vision), By Deployment (On-Cloud, On-Premise), By End-User (Healthcare, Automotive And Transportation, Agriculture, Information Technology (IT), Business Management, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Automotive Human-Machine Interfaces Global Market Report 2025 – By Product (Central Display, Voice Control System, Steering Mounted Control, Instrument Cluster, Head-Up Display, Rear Seat Entertainment, Multifunction Switch), By Technology (Visual Interface, Acoustic Interface, Other Technologies), By Access (Standard HMI, Multimodal HMI), By Function type (Primary, Secondary), By End User (Passenger Vehicle, Commercial Vehicle) – Market Size, Trends, And Global Forecast 2025-2034

View Report

High Voltage Electric Heater Global Market Report 2025 – By Type (Air Heaters, Coolant Heaters), By Heating Potential (Up to 4 KW, 4-7 KW, Above 7 KW), By Vehicle (Passenger Cars, LCVs, HCVs), By Vehicle Technology (Battery Electric Vehicles, Plug-in Hybrid Electric Vehicles, Hybrid Electric Vehicles) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Electronic Adhesives Global Market Report 2025 – By Resin Type( Epoxy, Silicone, Polyurethane, Acrylic, Other Resin Type), By Type( Non Conductive, Electrically Conductive, Thermally Conductive, Ultra Violet Curing), By Form( Liquid, Paste, Solid), By Application( Thermal Management, Conformal Coatings, Encapsulation, Surface Mounting, Wire Tacking, Soldering, Underfills, Sealing, Constructional), By End Use( Mobiles And Telecommunication Devices, Desktops And Networks, Televisions, Home Appliances, Automotive Electronics, Aerospace Electronics, Analytical And Measurement Instruments, Other End Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare RCM Outsourcing Global Market Report 2025 – By Type( Pre-intervention, Intervention, Post-intervention), By Service( Back-end, Middle, Front-end), By End User( Clinics, Hospitals, Ambulatory Surgery Centers, Other End users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Automotive Microcontrollers Market 2023 – By Type (8 Bit, 16 Bit, 32 Bit), By Vehicle Type (Passenger ICE Vehicle, Commercial ICE Vehicle, Electric Vehicle), By Connectivity (Vehicle To Vehicle (V2V) Connectivity, Vehicle To Infrastructure (V2I) Connectivity, Vehicle To Cloud (V2C) Connectivity), By Technology (Adaptive Cruise Control, Park Assist System, Blind Spot Detection, Tire Pressure Monitoring System), By Application Type (Powertrain and Chassis, Body Electronics, Safety And Security Systems, Infotainment And Telematics), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Frequently Asked Questions

What is the definition of the Methylmalonic Acidemia (MMA) market?

How will the Methylmalonic Acidemia (MMA) market drivers and restraints affect the market dynamics? What forces will shape the Methylmalonic Acidemia (MMA) industry going forward?

The Methylmalonic Acidemia (MMA) market major growth driver - Rising Incidence Of Metabolic Disorders And Vitamin Deficiencies Driving The Growth Of The Market Due To Impaired Vitamin B12 Metabolism. For further insights on the Methylmalonic Acidemia (MMA) market, request a sample here

What is the forecast market size or the forecast market value of the Methylmalonic Acidemia (MMA) market?

The Methylmalonic Acidemia (MMA) market size has grown strongly in recent years. The methylmalonic acidemia (MMA) market size has grown strongly in recent years. It will grow from $9.39 billion in 2024 to $9.97 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to the increasing incidence of metabolic disorders and vitamin deficiencies, increased healthcare expenditure, rise in health consciousness, increasing prevalence of genetic disorders, and growing demand from various end-user industries. The methylmalonic acidemia (MMA) market size is expected to see strong growth in the next few years. It will grow to $12.50 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing newborn screening programs, increased awareness among healthcare professionals, a rise in gene therapy advancements, rising investments in rare disease research, and increasing availability of specialized treatments. Major trends in the forecast period include advancements in gene editing technologies, advanced diagnostic techniques for early detection, advancements in enzyme replacement therapies, adoption of precision medicine approaches, and adoption of newborn genetic screening programs. For further insights on the Methylmalonic Acidemia (MMA) market, request a sample here

How is the Methylmalonic Acidemia (MMA) market segmented?

The Methylmalonic Acidemia (MMA) market covered in this report is segmented –
1) By Indication: Acidosis; Ketosis; Hyperammonemia; Hypoglycaemia; Hyperglycaemia; Neutropenia; Other Indications
2) By Disorder Type: Homocystinuria; Isolated Methylmalonic Acidurias; Combined methylmalonic Aciduria
3) By Distribution Channel: Hospitals; Pharmacies; Clinics; Other Distribution Channels

Subsegments:
1) By Acidosis: Metabolic Acidosis; Lactic Acidosis
2) By Ketosis: Starvation-Induced Ketosis; Diabetic Ketoacidosis
3) By Hyperammonemia: Acute Hyperammonemia; Chronic Hyperammonemia
4) By Hypoglycemia: Fasting Hypoglycemia; Reactive Hypoglycemi
5) By Hyperglycemia: Transient Hyperglycemia; Persistent Hyperglycemia
6) By Neutropenia: Severe Neutropenia; Cyclic Neutropenia
7) By Other Indications: Failure to Thrive; Developmental Delays; Neurological Symptoms; Renal Dysfunction For further insights on the Methylmalonic Acidemia (MMA) market, request a sample here

Which region has the largest share of the Methylmalonic Acidemia (MMA) market? What are the other regions covered in the report?

Who are the major players in the Methylmalonic Acidemia (MMA) market?

What are the key trends in the Methylmalonic Acidemia (MMA) market?

Major trends in the Methylmalonic Acidemia (MMA) market include Innovative mRNA-Based Therapies Pave The Way For Advanced Treatments. For further insights on the Methylmalonic Acidemia (MMA) market, request a sample here.

What are the major opportunities in the Methylmalonic Acidemia (MMA) market? What are the strategies for the Methylmalonic Acidemia (MMA) market?

For detailed insights on the major opportunities and strategies in the Methylmalonic Acidemia (MMA) market, request a sample here.

How does the Methylmalonic Acidemia (MMA) market relate to the overall economy and other similar markets?

For detailed insights on Methylmalonic Acidemia (MMA)'s relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Methylmalonic Acidemia (MMA) industry?

For detailed insights on the mergers and acquisitions in the Methylmalonic Acidemia (MMA) industry, request a sample here.

What are the key dynamics influencing the Methylmalonic Acidemia (MMA) market growth? SWOT analysis of the Methylmalonic Acidemia (MMA) market.

For detailed insights on the key dynamics influencing the Methylmalonic Acidemia (MMA) market growth and SWOT analysis of the Methylmalonic Acidemia (MMA) industry, request a sample here.